Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

Our analysis is essentially based on how ... between trends in earnings estimate revisions and short-term stock price movements. Pfizer is expected to post earnings of $0.67 per share for the ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

Secondly, I will conduct a comparative analysis of those Johnson ... in the next five years relative to Pfizer. In my opinion, Johnson & Johnson stock shows a number of signs of being overbought ...

Investors in Pfizer Inc. (NYSE:PFE) need to pay close attention to the stock based on moves in the options market lately. That... One stock that might be an intriguing choice for investors right ...

The city’s pharma giants avoided much of the initial turbulence felt by the rest of the economy in the wake of President Donald Trump’s sweeping tariffs. The S&P 500 cratered Thursday following news ...

Gold sell-off hitting interesting point Gold continues to suffer in the post-vaccine world. The Pfizer (NYSE:PFE) announcement... This article was written exclusively for Investing.com Or ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and Pfizer ...